Skip to main content
Tech.euFundingExplorerBeta

Refoxy Pharmaceuticals

The German startup is the first preclinical biotech company purposely developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases.

Berlin, Germanywww.refoxy.com ↗
Healthtech
← All companies
Total raised
€9.1M
€9,100,000
Funding rounds
1
Investors
4
distinct backers
Active since
2024-12
latest 2024-12

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood48
base rate 44% for Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2024-12-04Seed€9.1MApollo Health Ventures,Boehringer Ingelheim Venture Fund (BIVF),High-Tech Gründerfonds (HTGF),NRW VentureView deal →

Investors

4
Apollo Health VenturesBoehringer Ingelheim Venture Fund (BIVF)High-Tech Gründerfonds (HTGF)NRW Venture

Related news

Similar companies

same sector or country